Kurt von Emster

US·SEC (Form 4)

Vera Therapeutics, Inc.Jasper Therapeutics, Inc.CymaBay Therapeutics, Inc.

Cumul. flow

Total declarations

Companies

▲ Purchases (1 ops.)

€177k

▼ Sales (1 ops.)

€12k

Latest filing published 22 Mar 2024 for CymaBay Therapeutics, Inc.. Read the official filing

Filing timeline

BuySale

Kurt von Emster

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

T+90 mean return

-4.3%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Kurt von Emster: trading record in brief

Kurt von Emster has filed trades across 3 companies (mainly through SEC (Form 4)), most often in CymaBay Therapeutics, Inc., Jasper Therapeutics, Inc. and Vera Therapeutics, Inc. Over a trading history stretching from 17 May 2021 to 22 March 2024, the count stands at 5 filings.

In open-market terms, that means 1 purchase worth €177k on one side and 1 sale worth €12k on the other. On balance, insiders were net buyers of €164k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant and 1 option exercise.

On 22 March 2024 came the latest disclosure, a transaction in CymaBay Therapeutics, Inc. The last purchase on record was published on 18 May 2021, which is 1,979 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.